Results 201 to 210 of about 152,964 (318)
Molecular and immunohistochemical analysis of the bcl‐1/cyclin D1 gene in laryngeal squamous cell carcinomas [PDF]
, 1997 Nicola Fracchiolla +7 more
openalex +1 more source
MedComm – Oncology, Volume 4, Issue 3, September 2025.TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi +5 more
wiley +1 more source
RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression. [PDF]
Clinics (Sao Paulo)Zeng Z +6 more
europepmc +1 more source
Induction of p53 and melanoma cell death is reciprocal with down‐regulation of E2F, cyclin D1 and pRB [PDF]
, 1998 Manuel Rieber, Mary Strasberg–Rieber
openalex +1 more source
Fucoidan From Brown Algae as a Functional Food Ingredient: A Promising Anticancer Agent
eFood, Volume 6, Issue 4, August 2025.Fucoidan, a bioactive polysaccharide from brown algae, inhibits receptor tyrosine kinase (RTK) activation and vascular endothelial growth factor (VEGF) signaling, suppressing the phosphoinositide 3‐kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) and RAS/RAF/mitogen‐activated protein kinase/extracellular signal‐regulated kinase ...
Muhammad Umer Khan +7 more
wiley +1 more source
The evaluation of cyclin D1 expression in prostate carcinoma cases. [PDF]
North Clin IstanbAksoy A, Vicdanli S, Artas G.
europepmc +1 more source
Prognostic Significance of Cyclin D1 Expression in Small Intestinal Adenocarcinoma. [PDF]
Cancers (Basel), 2023 Jun SY, Hong SM, Jang KT.
europepmc +1 more source